- Advertisement -
Medtech startup Ceretas has secured the licence to commercialise a promising ultrasound therapy developed at The University of Queensland that could potentially restore brain function in people with Alzheimer’s disease.
Ceretas plans to progress the therapeutic ultrasound technology, developed by…

